Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Dalla Santa

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Immunology Letters|May 2, 2016
Reverse immunoediting: When immunity is edited by antigenAnna Merlo, Silvia Dalla Santa, Riccardo Dolcetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillanceAntonella Facchinetti, Silvia Dalla Santa, Silvio Mezzalira, et al.
Oncogene|September 12, 2020
Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemiaDeborah Bongiovanni, Valeria Tosello, Valentina Saccomani, et al.
Frontiers in Immunology|March 15, 2017
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T CellsElena Muraro, Anna Merlo, Debora Martorelli, et al.
Frontiers in Oncology|October 18, 2021
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation"Gaia Zuccolotto, Alessandro Penna, Giulio Fracasso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Predicting tumor outcome following cancer vaccination by monitoring quantitative and qualitative CD8+ T cell parametersAntonio Rosato, Alessia Zoso, Silvia Dalla Santa, et al.
Oncoimmunology|September 19, 2017
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1Anna Tosi, Silvia Dalla Santa, Elisa Cappuzzello, et al.
Haematologica|September 5, 2024
BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1Valeria Tosello, Ludovica Di Martino, Adonia E Papathanassiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacyAntonio Rosato, Alessia Zoso, Gabriella Milan, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2012
Survivin expression impacts prognostically on NSCLC but not SCLCAntonio Rosato, Chiara Menin, Daniela Boldrin, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Immunology Letters|May 2, 2016
Reverse immunoediting: When immunity is edited by antigenAnna Merlo, Silvia Dalla Santa, Riccardo Dolcetti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillanceAntonella Facchinetti, Silvia Dalla Santa, Silvio Mezzalira, et al.
Oncogene|September 12, 2020
Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemiaDeborah Bongiovanni, Valeria Tosello, Valentina Saccomani, et al.
Frontiers in Immunology|March 15, 2017
Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4<sup>+</sup> T CellsElena Muraro, Anna Merlo, Debora Martorelli, et al.
Frontiers in Oncology|October 18, 2021
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB "Super-Stimulation"Gaia Zuccolotto, Alessandro Penna, Giulio Fracasso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Predicting tumor outcome following cancer vaccination by monitoring quantitative and qualitative CD8+ T cell parametersAntonio Rosato, Alessia Zoso, Silvia Dalla Santa, et al.
Oncoimmunology|September 19, 2017
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1Anna Tosi, Silvia Dalla Santa, Elisa Cappuzzello, et al.
Haematologica|September 5, 2024
BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1Valeria Tosello, Ludovica Di Martino, Adonia E Papathanassiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 11, 2003
Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacyAntonio Rosato, Alessia Zoso, Gabriella Milan, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2012
Survivin expression impacts prognostically on NSCLC but not SCLCAntonio Rosato, Chiara Menin, Daniela Boldrin, et al.
Pageof 2